Akebia Therapeutics Inc. (AKBA)
NASDAQ: AKBA
· Real-Time Price · USD
3.30
0.01 (0.30%)
At close: Aug 15, 2025, 2:18 PM
Akebia Therapeutics Revenue
Akebia Therapeutics reported an annual revenue of $160.18M, reflecting a -17.7% growth. For the quarter ending March 31, 2025, Akebia Therapeutics generated $57.34M in revenue.
Revenue (ttm)
160.18M
Revenue Growth
-17.7%
Price / Sales Ratio
2.5
Revenue / Employee
884.97K
Employees
181
Market Cap
874.98M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|